{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:21:41Z","timestamp":1777288901885,"version":"3.51.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A bone lesion in the right calcaneus was found in a 76-year-old man with a history of prostate cancer.\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA-11 PET\/CT showed multiple PSMA-expressing lytic bone lesions in appendicular skeleton. Biopsy of the lesion in the right calcaneus confirmed plasmacytoma. After several cycles of chemotherapy, the patient was in serologically stringent complete remission. The follow-up PET\/CT showed a significant reduction of\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA-11 uptake in the previously PSMA-avid bone lesions without morphological changes on CT. The reduction of PSMA expression in myelomas after chemotherapy is suggested to result from the treatment response.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000003339","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T09:00:17Z","timestamp":1603270817000},"page":"1013-1015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Change of 68Ga\u2013Prostate-Specific Membrane Antigen Uptake in Myeloma After Chemotherapy in a Patient With Multiple Myeloma and Concurrent Prostate Cancer"],"prefix":"10.1097","volume":"45","author":[{"given":"Qingqing","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"bib1-20260120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20260120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-018-4066-4","article-title":"68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng\/ml. Efficacy and impact on treatment strategy","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20260120","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"bib4-20260120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.117.203570","article-title":"Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib5-20260120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000447688","article-title":"Prostate-specific membrane antigen PET\/CT: false-positive results due to sarcoidosis?","volume":"9","year":"2016","journal-title":"Case Rep Oncol"},{"key":"bib6-20260120","first-page":"1654231","article-title":"PSMA-PET\/CT-positive Paget disease in a patient with newly diagnosed prostate cancer: imaging and bone biopsy findings","volume":"2017","year":"2017","journal-title":"Case Rep Urol"},{"key":"bib7-20260120","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/RLU.0000000000002682","article-title":"Multiple solitary plasmacytomas with multifocal bone involvement diagnosed with 68Ga-prostate-specific membrane antigen PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20260120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/RLU.0000000000001773","article-title":"Vertebral myeloma mimicking prostatic carcinoma metastasis in 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib9-20260120","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/RLU.0000000000001479","article-title":"68Ga-PSMA PET\/CT imaging in multiple myeloma","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib10-20260120","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/RLU.0000000000001649","article-title":"Image of the month: multifocal 68Ga prostate-specific membrane antigen ligand uptake in the skeleton in a man with both prostate cancer and multiple myeloma","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib11-20260120","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T22:00:24Z","timestamp":1768946424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003339","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}